Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00256698 · OUTCOME

Overall Survival (OS)

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy · Source last updated 2012-08-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
months
Interval / dispersion
Full Range
Time frame
All deaths occurring between randomisation and data cut-off on 30th April 2009 are included.

What was measured

Overall survival is equivalent to time to death. Time from randomisation until the date of death

Groups in this outcome

Fulvestrant + Anastrozole

Fulvestrant 250 mg Loading Dose Regimen + Anastrozole 1 mg

Anastrozole

Anastrozole 1 mg

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Fulvestrant + Anastrozole258
Anastrozole256

Reported measurements

Source class 1
Values in months · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Fulvestrant + Anastrozole37.8Not reported0.0761.86Not reported
Anastrozole38.2Not reported0.1360.39Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.07
        upper Limit
        61.86
        value
        37.8
      2. group Id
        OG001
        lower Limit
        0.13
        upper Limit
        60.39
        value
        38.2
denoms
  1. counts
    1. group Id
      OG000
      value
      258
    2. group Id
      OG001
      value
      256
    units
    Participants
description
Overall survival is equivalent to time to death. Time from randomisation until the date of death
dispersion Type
Full Range
groups
  1. description
    Fulvestrant 250 mg Loading Dose Regimen + Anastrozole 1 mg
    id
    OG000
    title
    Fulvestrant + Anastrozole
  2. description
    Anastrozole 1 mg
    id
    OG001
    title
    Anastrozole
param Type
MEDIAN
reporting Status
POSTED
time Frame
All deaths occurring between randomisation and data cut-off on 30th April 2009 are included.
title
Overall Survival (OS)
type
SECONDARY
unit Of Measure
months

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice